91 results
Page 4 of 5
S-4
EX-10.18
xiyw 0d3fx8
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.6
lzbrzopkc9uobbm
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.12
mktyx
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.8
zinyjw d2
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.13
82xxhux1powaauf
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.9
j1d kx8wowlghfzr
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.11
il8wjehepthh
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
28p1lc
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K/A
EX-10.1
tr5dxtl q6kye
18 Mar 21
Financial Statements and Exhibits
9:08am
425
yl3g2fy cxh
15 Mar 21
Business combination disclosure
8:20am
8-K
or7 qtbzl6xa
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am
10-K
hl86gllalwumzlah9n
5 Mar 21
Annual report
8:13am
10-K
EX-31.1
tijp2o
5 Mar 21
Annual report
8:13am
10-K
EX-31.2
0tpib r0q
5 Mar 21
Annual report
8:13am
10-Q
EX-31.1
etam c8jt71exv
20 Aug 20
Quarterly report
4:15pm
10-Q
EX-31.2
ziid734ohj9il0s11b
20 Aug 20
Quarterly report
4:15pm
8-K
EX-99.1
ookzjvysoeuvbt1dzs
16 Jul 20
Report of Independent Registered Public Accounting Firm
4:30pm
8-K
EX-10.5
x005iigw
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm